C57BL/6-Atm1Brd Mtrfrtm1(KOMP)Mbp/Oulu

Status

Available to order

EMMA IDEM:09863
Citation informationRRID:IMSR_EM:09863 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6-Atm1Brd Mtrfrtm1(KOMP)Mbp/Oulu
Alternative name2810006K23Riktm1(KOMP)Mbp
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolMtrfrtm1(KOMP)Mbp
Gene/Transgene symbolMtrfr

Information from provider

ProviderBrendan Battersby
Provider affiliationUniversity of Helsinki
Genetic informationReporter-tagged deletion allele (with selection cassette). Generated from ES cell line DEPD00502_6_E10.
Phenotypic informationHomozygous:
NA

Heterozygous:
NA
Breeding historyChimeric males were bred with wild-type females to produce heterozygotes. Sperm was isolated and cryopreserved from heterozygous males and quality tested by IVF.
References
  • Evaluating the feasibility of gene replacement strategies to treat MTRFR deficiency.;Pratt Samia L, Zarate-Mendez Mariana, Koludarova Lidiia, Jansson Sonja, Airavaara Mikko, Hlushchuk Irena, Coleman David, Heffner Caleb, Horvath Rita, Battersby Brendan J, Burgess Robert W, ;2025;Disease models & mechanisms;18;; 40452409
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requirednot known
Immunocompromisednot known

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland
Animals used for archivingheterozygous C57BL/6NCrl;C57BL/6JOlaHsd males, wild-type C57BL/6JOlaHsd females
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Evaluating the feasibility of gene replacement strategies to treat MTRFR deficiency.;Pratt Samia L, Zarate-Mendez Mariana, Koludarova Lidiia, Jansson Sonja, Airavaara Mikko, Hlushchuk Irena, Coleman David, Heffner Caleb, Horvath Rita, Battersby Brendan J, Burgess Robert W, ;2025;Disease models & mechanisms;18;; 40452409

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).